College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States.
Department of Health Services Research, Management, and Policy, University of Florida, Gainesville, FL, United States.
Curr Diabetes Rev. 2023;19(5):e090622205804. doi: 10.2174/1573399818666220609154132.
People with type 1 diabetes (T1D) face heightened risks for morbidity and mortality from the 2019 Coronavirus (COVID-19). They also have elevated risks for disparate psychological outcomes during the COVID-19 pandemic, given their predisposition to mental health disorders, including anxiety and depression, and skyrocketing rates of these conditions among the general population.
To investigate the psychological ramifications of the COVID-19 pandemic on people with T1D globally, we conducted a scoping review of recent literature across eight online databases. Articles were screened via a rigorous process, and data pertaining to psychological outcomes were coded into thematic areas for analysis.
Forty articles presenting data from 27 countries and 14 categories of psychological outcomes affecting people with T1D were included in this review. Psychological outcomes, in order of most to least frequently identified, included: stress, anxiety, social factors, worry, distress, fear, sleep habits, quality of life, depression, attitudes regarding COVID-19, other psychological issues, mental health services utilization, burnout, and temperament. Recurring findings demonstrated significant increases in the prevalence of mental health conditions, changes in sleeping habits, reductions of social support, and extensive psychosocial concerns among people with T1D. Associations between patients' psychological issues and demographic characteristics, diabetes self-management behaviors, glycemic control, and overall wellbeing were evident.
During the COVID-19 pandemic, people with T1D experienced pervasive psychological burdens. This review calls for further research examining the long-term impacts of the pandemic and strengthens awareness of the need for interventions to offset psychological challenges affecting people with T1D.
1 型糖尿病(T1D)患者面临着更高的发病率和死亡率的风险,而 COVID-19 就是其中之一。此外,由于他们更容易患精神健康障碍,包括焦虑和抑郁,以及这些疾病在普通人群中的发病率飙升,因此他们在 COVID-19 大流行期间也面临着不同的心理后果的风险。
为了研究 COVID-19 大流行对全球 T1D 患者的心理影响,我们对八大在线数据库中的最新文献进行了范围广泛的综述。文章通过严格的流程进行筛选,将与心理结果相关的数据编码为主题分析。
共有 40 篇文章从 27 个国家和 14 个类别呈现了 T1D 患者的心理结果,这些文章被纳入本综述。按照最常出现到最不常出现的顺序,心理结果包括:压力、焦虑、社会因素、担忧、苦恼、恐惧、睡眠习惯、生活质量、抑郁、对 COVID-19 的态度、其他心理问题、心理健康服务利用、倦怠和气质。反复出现的发现表明,T1D 患者的心理健康状况明显增加,睡眠习惯发生变化,社会支持减少,以及广泛的心理社会问题。患者的心理问题与人口统计学特征、糖尿病自我管理行为、血糖控制和整体健康状况之间存在关联。
在 COVID-19 大流行期间,T1D 患者经历了普遍的心理负担。本综述呼吁进一步研究大流行的长期影响,并加强对需要干预措施以缓解影响 T1D 患者的心理挑战的认识。